The association of the platelet/high-density lipoprotein cholesterol ratio with self-reported stroke and cardiovascular mortality: a population-based observational study

Table 3 Weighted multivariate Cox regression analysis for the association of CVD mortality with PHR and HDL-C

PHR	Model 0		Model 1		Model 2		Model 3
	HR (95% CI)	P	HR (95% CI)	P	HR (95% CI)	P	HR (95% CI)	P
Per SD increase	1.07(0.93,1.23)	0.33	1.11(1.03,1.19)	0.01	1.10(1.02,1.18)	0.01	1.14(1.06,1.22)	< 0.001
Per 100 increase	1.07(0.94,1.21)	0.33	1.10(1.03,1.18)	0.01	1.10(1.02,1.17)	0.01	1.13(1.06,1.21)	< 0.001
HDL-C	Model 0		Model 1		Model 2		Model 3
	HR (95% CI)	P	HR (95% CI)	P	HR (95% CI)	P	HR (95% CI)	P
Per SD increase	0.86(0.70,1.06)	0.17	0.82(0.65,1.04)	0.10	0.84(0.66,1.06)	0.14	0.83(0.66,1.05)	0.13
Per 1 increase	0.70(0.42,1.16)	0.17	0.63(0.36,1.10)	0.10	0.66(0.38,1.15)	0.14	0.65(0.37,1.13)	0.13

Model 0: Not adjusted
Model 1: Adjusted for age and sex
Model 2: Further adjusted for marital status, smoking, and drinking status based on Model 1
Model 3: Further adjusted for thyroid problems, cancer, CHD, and CKD based on Model 2
Abbreviations: HDL-C High-density lipoprotein cholesterol, PHR Platelet-to-high-density lipoprotein cholesterol ratio, CVD Cardiovascular disease, CHD Coronary heart disease, CKD Chronic kidney disease, SD Standard deviation, HR Hazard ratio, CI Confidence interval

ISSN: 1476-511X